<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> presented with severe <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo>, a previously unreported complication of this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Roentgenograms and radionuclide scans showed multiple osteolytic lesions in both patients </plain></SENT>
<SENT sid="2" pm="."><plain>Plasma parathyroid hormone (PTH) was undetectable during the <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo> phase </plain></SENT>
<SENT sid="3" pm="."><plain>Chemotherapy was followed by rapid <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> lysis, <z:hpo ids='HP_0002905'>hyperphosphatemia</z:hpo>, <z:hpo ids='HP_0003109'>phosphaturia</z:hpo> and <z:hpo ids='HP_0002901'>hypocalcemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The hypocalcemic phase persisted for two weeks despite rapid normalization of serum <z:chebi fb="81" ids="28659,35895">phosphorus</z:chebi> and renal function </plain></SENT>
<SENT sid="5" pm="."><plain>Measurement of urinary cyclic <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>, an index of PTH action, indicated that parathyroid function had been suppressed by the <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo> and remained suppressed for almost one week despite marked <z:hpo ids='HP_0002901'>hypocalcemia</z:hpo> </plain></SENT>
</text></document>